WesBanco Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$735K Buy
1,901
+706
+59% +$262K 0.02% 432
2026
Q1
$350K Sell
1,195
-52
-4% -$17.1K 0.01% 555
2025
Q4
$437K Sell
1,247
-11
-0.9% -$3.72K 0.01% 519
2025
Q3
$406K Sell
1,258
-3
-0.2% -$933 0.01% 534
2025
Q2
$490K Sell
1,261
-9
-0.7% -$3.62K 0.01% 475
2025
Q1
$552K Sell
1,270
-29
-2% -$11.6K 0.02% 413
2024
Q4
$479K Sell
1,299
-36
-3% -$15.1K 0.02% 441
2024
Q3
$694K Sell
1,335
-80
-6% -$42.7K 0.02% 379
2024
Q2
$767K Sell
1,415
-21
-1% -$11.1K 0.03% 343
2024
Q1
$745K Sell
1,436
-28
-2% -$13.9K 0.03% 346
2023
Q4
$690K Hold
1,464
0.04% 220
2023
Q3
$637K Sell
1,464
-25
-2% -$11.3K 0.03% 358
2023
Q2
$661K Sell
1,489
-8
-0.5% -$3.69K 0.03% 349
2023
Q1
$688K Hold
1,497
0.03% 345
2022
Q4
$768K Hold
1,497
0.03% 316
2022
Q3
$680K Sell
1,497
-194
-11% -$92.8K 0.05% 214
2022
Q2
$816K Sell
1,691
-25
-1% -$12.4K 0.04% 303
2022
Q1
$843K Sell
1,716
-706
-29% -$323K 0.03% 321
2021
Q4
$1.12M Buy
2,422
+10
+0.4% +$4.21K 0.04% 283
2021
Q3
$899K Sell
2,412
-91
-4% -$34.6K 0.03% 311
2021
Q2
$956K Buy
2,503
+100
+4% +$38.2K 0.04% 308
2021
Q1
$862K Buy
+2,403
New +$773K 0.03% 312
2020
Q3
$626K Hold
2,330
0.03% 329
2020
Q2
$612K Sell
2,330
-11
-0.5% -$2.94K 0.03% 324
2020
Q1
$532K Sell
2,341
-172
-7% -$46.9K 0.03% 318
2019
Q4
$759K Buy
2,513
+17
+0.7% +$4.68K 0.03% 314
2019
Q3
$599K Sell
2,496
-220
-8% -$60.3K 0.03% 342
2019
Q2
$766K Sell
2,716
-125
-4% -$34.1K 0.04% 298
2019
Q1
$815K Buy
2,841
+954
+51% +$276K 0.04% 285
2018
Q4
$495K Sell
1,887
-21
-1% -$5.77K 0.03% 322
2018
Q3
$523K Sell
1,908
-70
-4% -$18.2K 0.03% 360
2018
Q2
$470K Sell
1,978
-20
-1% -$4.63K 0.02% 369
2018
Q1
$439K Hold
1,998
0.02% 387
2017
Q4
$449K Hold
1,998
0.03% 273
2017
Q3
$379K Hold
1,998
0.02% 391
2017
Q2
$376K Hold
1,998
0.02% 382
2017
Q1
$331K Hold
1,998
0.02% 387
2016
Q4
$287K Hold
1,998
0.02% 408
2016
Q3
$250K Hold
1,998
0.01% 424
2016
Q2
$262K Sell
1,998
-500
-20% -$68.4K 0.02% 417
2016
Q1
$347K Hold
2,498
0.02% 361
2015
Q4
$348K Hold
2,498
0.02% 365
2015
Q3
$350K Sell
2,498
-350
-12% -$52.6K 0.02% 363
2015
Q2
$468K Sell
2,848
-3
-0.1% -$479 0.03% 340
2015
Q1
$441K Hold
2,851
0.02% 354
2014
Q4
$358K Buy
2,851
+100
+4% +$12.4K 0.02% 389
2014
Q3
$329K Sell
2,751
-6
-0.2% -$688 0.02% 406
2014
Q2
$296K Sell
2,757
-224
-8% -$23.1K 0.02% 422
2014
Q1
$297K Hold
2,981
0.02% 427
2013
Q4
$275K Buy
2,981
+242
+9% +$21.5K 0.02% 440
2013
Q3
$229K Sell
2,739
-300
-10% -$25.7K 0.01% 464
2013
Q2
$249K Buy
+3,039
New +$227K 0.02% 439

Other funds holding ELV

WesBanco Bank's ELV Position: Q2 2026 in Review

WesBanco Bank increased its Elevance Health (ELV) stake by 59% in Q2 2026, buying an estimated $262K and bringing the position to 1,901 shares worth $735K. The position accounts for 0.02% of the portfolio, ranked #432.

WesBanco Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12M in Q4 2021. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • WesBanco Bank held 1,901 shares of Elevance Health worth $735K as of Q2 2026.
  • WesBanco Bank bought 706 Elevance Health shares in Q2 2026, an estimated $262K.
  • Elevance Health made up 0.02% of WesBanco Bank's portfolio in Q2 2026, its #432 holding.
  • WesBanco Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's Elevance Health position peaked at $1.12M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.